Insider · CIK 0002009236
Jason Pitofsky
officer
Files at REGN (REGENERON PHARMACEUTICALS, INC.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 16, 2024 | REGN REGENERON PHARMACEUTICALS, INC. | FTax withholding Common Stock | -298 | $730.81 | $218k | 4,664 | Dec 18, 2024 |
| Dec 6, 2024 | REGN REGENERON PHARMACEUTICALS, INC. | AGrant or award Common Stock | +907 | $0.00 | $0 | 5,111 | Dec 10, 2024 |
| Dec 9, 2024 | REGN REGENERON PHARMACEUTICALS, INC. | FTax withholding Common Stock | -149 | $787.00 | $117k | 4,962 | Dec 10, 2024 |
| Apr 4, 2024 | REGN REGENERON PHARMACEUTICALS, INC. | GGift Common Stockindirect: By Trust | +89 | $0.00 | $0 | 89 | Dec 10, 2024 |
| Apr 29, 2024 | REGN REGENERON PHARMACEUTICALS, INC. | GGift Common Stockindirect: By Trust | +90 | $0.00 | $0 | 179 | Dec 10, 2024 |
| Dec 6, 2024 | REGN REGENERON PHARMACEUTICALS, INC. | AGrant or award Non-Qualified Stock Option (right to buy)derivative | +3,236 | $0.00 | $0 | 3,236 | Dec 10, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.